메뉴 건너뛰기




Volumn 53, Issue 10, 1996, Pages 1164-1166

Weight-based protocol for improving heparin therapy

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN;

EID: 0029920796     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.10.1164     Document Type: Review
Times cited : (8)

References (7)
  • 1
    • 0023003183 scopus 로고
    • Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis
    • Hull RD, Raskob GE, Hirsch J et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med. 1986; 315:1109-14.
    • (1986) N Engl J Med , vol.315 , pp. 1109-1114
    • Hull, R.D.1    Raskob, G.E.2    Hirsch, J.3
  • 2
    • 0025326059 scopus 로고
    • Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis
    • Hull RD, Raskob GE, Resenblood D et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med. 1990; 332:1260-4.
    • (1990) N Engl J Med , vol.332 , pp. 1260-1264
    • Hull, R.D.1    Raskob, G.E.2    Resenblood, D.3
  • 3
    • 0026022024 scopus 로고
    • A standard heparin nomogram for the management of heparin therapy
    • Cruickshank MK, Levine MN, Hirsch J et al. A standard heparin nomogram for the management of heparin therapy. Arch Intern Med. 1991; 151:33-7.
    • (1991) Arch Intern Med , vol.151 , pp. 33-37
    • Cruickshank, M.K.1    Levine, M.N.2    Hirsch, J.3
  • 4
    • 3042924956 scopus 로고
    • The global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO) pilot study: Combined streptokinase and t-PA
    • Abstract
    • Granger C, Kalbfleisch J, Califf R et al. The global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO) pilot study: combined streptokinase and t-PA. Circulation. 1991; 84(suppl II):II-573. Abstract.
    • (1991) Circulation , vol.84 , Issue.2 SUPPL.
    • Granger, C.1    Kalbfleisch, J.2    Califf, R.3
  • 5
    • 2642704604 scopus 로고
    • Individualizing heparin dosage improves anticoagulation and may reduce hemorrhagic complications following coronary thrombolysis
    • Paper presented New Orleans, LA; December 11
    • Zimmerman C, Skarr D, Boyle M et al. Individualizing heparin dosage improves anticoagulation and may reduce hemorrhagic complications following coronary thrombolysis. Paper presented at ASHP Midyear Clinical Meeting. New Orleans, LA; 1991 December 11.
    • (1991) ASHP Midyear Clinical Meeting
    • Zimmerman, C.1    Skarr, D.2    Boyle, M.3
  • 6
    • 0027416008 scopus 로고
    • Pharmacy-managed weight-based heparin protocol
    • Rivey MP, Peterson JP. Pharmacy-managed weight-based heparin protocol. Am J Hasp Pharm. 1993; 50:279-84.
    • (1993) Am J Hasp Pharm , vol.50 , pp. 279-284
    • Rivey, M.P.1    Peterson, J.P.2
  • 7
    • 0027517894 scopus 로고
    • The weight-based heparin dosing nomogram compared with a "standard care" nomogram: A randomized controlled trial
    • Raschke PA, Reilly BM, Guidry JR et al. The weight-based heparin dosing nomogram compared with a "standard care" nomogram: a randomized controlled trial. Ann Intern Med. 1993; 119:874-81.
    • (1993) Ann Intern Med , vol.119 , pp. 874-881
    • Raschke, P.A.1    Reilly, B.M.2    Guidry, J.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.